Board of Directors

Paul E. Mann co-founded ASP Isotopes Inc. in September 2021 and has served as the Chairman and Chief Executive Officer and a member of its board of directors of ASP Isotopes Inc. since incorporation. Paul also served as the Chief Financial Officer of ASP Isotopes Inc. until September 2022. Prior to ASPI, Paul was Chief Financial Officer of PolarityTE, Inc., a biotechnology company, from June 2018 until April 2020. Prior to that, he was responsible for Healthcare investments at DSAM Partners LLC, a global hedge fund. Earlier in his career, he was a portfolio manager at Highbridge Capital where he managed investments in healthcare and biotechnology. Prior to Highbridge Capital, from August 2013 to March 2016, he worked at Soros Fund Management where he was responsible for billions of dollars of investments in healthcare and chemicals companies. During his career as a healthcare and chemicals investor, Paul has helped create and fund numerous early stage and start-up companies. Prior to moving to the buy-side, Paul spent 11 years as a sell-side analyst at Morgan Stanley and Deutsche Bank. He co-managed the healthcare research team at Morgan Stanley, one of the top ranked teams in Institutional Investor, Greenwich and Reuters. He was also corporate broker to over half the UK Pharmaceutical Companies. Paul started his career as a research scientist at Procter and Gamble and he is named as the inventor of numerous skin creams in the Oil of Olay range of cosmetics. Between 2000 and 2023 he was a nonexecutive, independent director at Abeona Therapeutics (NASDAQ: ABEO), where he was the chair of the audit committee, and he is currently a director at Healthtech Solution Inc. (OTC: HLTT), where he is chairman of the board and serves on the audit committee. He was the co-founder and Chairman of Varian Biopharma, a private biotechnology company focused on precision oncology until its sale in 2023. Paul has an MA (Cantab) and an MEng from Cambridge University, UK where he studied Natural Sciences and Chemical Engineering and he is a CFA charter holder.

Mr. John Melkon is currently a senior advisor to the United States Military Academy at West Point.  Previously, from 2012 to 2026 he was a Director and an Assistant Professor at the United States Military Academy and has been recently charged with building and leading the Critical Minerals Consortium. In this capacity he is responsible for facilitating the coordination, planning and execution of the strategic vision and mission to educate faculty, cadets and the community of practice. He also teaches Seminars on Sub-Saharan African Geography, as well as the Geography of the Middle East and North Africa. He serves as a Co-Chair for the Bilateral Defense Committee between the U.S. and South Africa.

Prior to his service at CSCMO (Center for the Study of Civil/Military Operations), Mr. Melkon served as a Senior Operations Advisor to the United States Army Africa in Vicenza, Italy from 2009 to 2012. He was responsible for providing strategic liaison to Inter-Agency and multi-national partners and advising the command on critical operational planning. During that tenure he served the command in OPERATION ODYSSEY DAWN. He was also a Strategic Operations Officer for the Department of Defense from 2006 to 2009 with service to OPERATION ENDURING FREEDOM. Before re-entering public service Mr. Melkon worked as an International Banking Associate for Credit Suisse First Boston in Frankfurt, Germany.

Prior to his civilian service with CSFB, Mr. Melkon was an Army Special Forces Officer and in over thirty years of national security service to the United States of America, Mr. Melkon has had operational and combat experience in Europe, Africa, the Middle East, and Central and South East Asia. His expertise spans a wide range of Civil-Military Operations, Unconventional Warfare, Counterterrorism, Counterinsurgency and Foreign Internal Defense. He is a graduate of the National Senior Intelligence Course and also an FBI Certified Crisis Negotiator.

Mr. Melkon is currently a PhD Candidate at Stellenbosch University along with a Professor of Practice at North West University in South Africa.  He received his A.B. in History from Princeton University, and he also holds an MBA from the Lowry Mays School of Business and an MPIA with honors from the George Bush School of Government and Public Service at Texas A&M University. He has been conferred an MA in European Politics and a Certificate of Professional Achievement in Enterprise Risk Management from Columbia University in 2022. He is also a Harvard John F Kennedy School Senior Executive in National and International Security.

Mr. Yu is a director of the Company and has over 10 years of experience in auditing, accounting and financial management.

Dr. Pretorius is an independent director of the Company with over 15 years of experience in process engineering and project management across the minerals, metals and energy sectors.

Mr. Rowe is an independent director of the Company with experience in business development and engineering management.